Show simple item record

dc.contributor.authorStone, TJ
dc.contributor.authorMankad, K
dc.contributor.authorTan, AP
dc.contributor.authorJan, W
dc.contributor.authorPickles, JC
dc.contributor.authorGogou, M
dc.contributor.authorChalker, J
dc.contributor.authorSlodkowska, I
dc.contributor.authorPang, E
dc.contributor.authorKristiansen, M
dc.contributor.authorMadhan, GK
dc.contributor.authorForrest, L
dc.contributor.authorHughes, D
dc.contributor.authorKoutroumanidou, E
dc.contributor.authorMistry, T
dc.contributor.authorOgunbiyi, O
dc.contributor.authorAhmed, SW
dc.contributor.authorCross, JH
dc.contributor.authorHubank, M
dc.contributor.authorHargrave, D
dc.contributor.authorJacques, TS
dc.coverage.spatialEngland
dc.date.accessioned2023-06-02T10:24:52Z
dc.date.available2023-06-02T10:24:52Z
dc.date.issued2023-04-01
dc.identifierARTN e12894
dc.identifier.citationNeuropathology and Applied Neurobiology, 2023, 49 (2), pp. e12894 -en_US
dc.identifier.issn0305-1846
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/5822
dc.identifier.eissn1365-2990
dc.identifier.eissn1365-2990
dc.identifier.doi10.1111/nan.12894
dc.description.abstractAIMS: Glioneuronal tumours (GNTs) are poorly distinguished by their histology and lack robust diagnostic indicators. Previously, we showed that common GNTs comprise two molecularly distinct groups, correlating poorly with histology. To refine diagnosis, we constructed a methylation-based model for GNT classification, subsequently evaluating standards for molecular stratification by methylation, histology and radiology. METHODS: We comprehensively analysed methylation, radiology and histology for 83 GNT samples: a training cohort of 49, previously classified into molecularly defined groups by genomic profiles, plus a validation cohort of 34. We identified histological and radiological correlates to molecular classification and constructed a methylation-based support vector machine (SVM) model for prediction. Subsequently, we contrasted methylation, radiological and histological classifications in validation GNTs. RESULTS: By methylation clustering, all training and 23/34 validation GNTs segregated into two groups, the remaining 11 clustering alongside control cortex. Histological review identified prominent astrocytic/oligodendrocyte-like components, dysplastic neurons and a specific glioneuronal element as discriminators between groups. However, these were present in only a subset of tumours. Radiological review identified location, margin definition, enhancement and T2 FLAIR-rim sign as discriminators. When validation GNTs were classified by SVM, 22/23 classified correctly, comparing favourably against histology and radiology that resolved 17/22 and 15/21, respectively, where data were available for comparison. CONCLUSIONS: Diagnostic criteria inadequately reflect glioneuronal tumour biology, leaving a proportion unresolvable. In the largest cohort of molecularly defined glioneuronal tumours, we develop molecular, histological and radiological approaches for biologically meaningful classification and demonstrate almost all cases are resolvable, emphasising the importance of an integrated diagnostic approach.
dc.formatPrint
dc.format.extente12894 -
dc.languageeng
dc.language.isoengen_US
dc.publisherWILEYen_US
dc.relation.ispartofNeuropathology and Applied Neurobiology
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.subjectdysembryoplastic neuroepithelial tumour
dc.subjectganglioglioma
dc.subjectglioneuronal tumour
dc.subjectmachine learning
dc.subjectmolecular pathology
dc.subjectHumans
dc.subjectBrain Neoplasms
dc.subjectDNA Methylation
dc.subjectNeoplasms, Neuroepithelial
dc.subjectCentral Nervous System Neoplasms
dc.subjectRadiology
dc.titleDNA methylation-based classification of glioneuronal tumours synergises with histology and radiology to refine accurate molecular stratification.en_US
dc.typeJournal Article
dcterms.dateAccepted2023-02-21
dc.date.updated2023-06-02T10:24:07Z
rioxxterms.versionVoRen_US
rioxxterms.versionofrecord10.1111/nan.12894en_US
rioxxterms.licenseref.startdate2023-04-01
rioxxterms.typeJournal Article/Reviewen_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/36843390
pubs.issue2
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Translational Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Translational Genomics/Translational Genomics (hon.)
pubs.publication-statusPublished
pubs.publisher-urlhttp://dx.doi.org/10.1111/nan.12894
pubs.volume49
dc.contributor.icrauthorHubank, Michael
icr.provenanceDeposited by Mr Arek Surman on 2023-06-02. Deposit type is initial. No. of files: 1. Files: Neuropathology Appl Neurobio - 2023 - Stone - DNA methylation‐based classification of glioneuronal tumours synergises with.pdf


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/